Umb Bank, N.A. Arrowhead Pharmaceuticals, Inc. Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
A detailed history of Umb Bank, N.A. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 731 shares of ARWR stock, worth $13,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
731
Previous 537
36.13%
Holding current value
$13,698
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
293Shares Held
90.6MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$229 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$167 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$119 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$91.5 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.98B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...